Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
1-10
employees, estimated range
Grants
$1.3M
2 grants · CORDIS
Backers
1
imperialcollege
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 15, 2024 Won a grant $998k · CORDIS Oct 1, 2020 Won a grant $256k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Mar 2024 $998k — CORDIS
Grant Oct 2020 $256k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Asgard TherapeuticsSeries A $32.4M · 2 yr ago • 51-200 employees
Reprogramming is the next leap forward in cancer immunotherapy. Asgard Therapeutics is a Swedish private biotech company exploring direct…
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of…
ALKemist BioVenture round $7.5M · 2 yr ago • 11-50 employees
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
0 APstem is committed to addressing the world's most challenging and currently incurable diseases. APstem was founded on a breakthrough…
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.

Overview

OmniCyte is a pre-clinical biotech company addressing significant unmet needs in cancer.

Offices

Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Guilford United States
HQ
Branford United States
Regional office
Business Park Drive, Branford CT 06405 Email: [email protected] Tel: +1 (917) 439-7479
Business Park Drive, Branford CT 06405
company site
New York United States
Regional office
80 Fifth Avenue 10th Floor, New York NY 10011
80 Fifth Avenue 10th Floor, New York NY 10011
company site

Financials

Total raised
$1.3M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2024 $998k Details
Grant 2020 $256k Details